Cardiac Resynchronization Therapy
Remote monitoring of implanted devices with a universal platform improves outcomes
Use of a third-party universal remote monitoring platform was linked to better survival and hospitalization outcomes than conventional remote monitoring or no monitoring in patients with implanted cardiac devices, researchers reported.
In nonischemic cardiomyopathy, women with CRT-D appear to have best outcomes: BIO-LIBRA
In patients with nonischemic cardiomyopathy, women had lower rates of ventricular arrhythmias and death than men, especially if they had a cardiac resynchronization therapy defibrillator, according to the results of the BIO-LIBRA study.
BMAD-HF
Assessing a novel, stick-on thoracic fluid monitor (Microcor, Zoll Medical) for HF management.
More antibiotics may not benefit high-risk patients undergoing cardiac device implantation
Antibiotic irrigation and oral antibiotics on top of chlorhexidine skin preparation, IV antibiotics and antibiotic envelope did not provide additional benefit for high-risk patients after cardiac device implantation, researchers reported.
Lower use of guideline-recommended HF therapies at rural vs. urban hospitals
NEW ORLEANS — Patients with HF at rural hospitals were significantly less likely to receive guideline-directed medical therapy at discharge compared with urban hospitals, but other quality metrics were similar, researchers reported.
Extent of RV remodeling prior to CRT may predict survival in patients with chronic HF
More advanced right ventricular remodeling prior to cardiac resynchronization therapy for chronic HF was independently associated with reduced 5-year survival, researchers reported.
FDA designates recall of ICD, CRT devices as class I
The FDA announced Medtronic has issued a recall of its implantable cardioverter defibrillators and cardiac resynchronization therapy devices due to a short circuit protection alert resulting in reduced-energy electric shock delivery.
First, recurrent tachycardia less likely in women vs. men with primary prevention ICD
Women with HF who received an implantable cardioverter defibrillator for primary prevention were less likely to experience first and recurrent life-threatening ventricular tachycardias compared with men, researchers reported.
Most patients with implantable device infections do not receive extraction
WASHINGTON — Contrary to guideline recommendations, most patients with infections related to implantable cardiac devices do not get their devices explanted, despite extraction leading to better outcomes, researchers reported.
CRT devices, His bundle pacing, reducing complications focus of new ESC pacing guideline
Among the features of the new European Society of Cardiology guideline on pacing and cardiac resynchronization therapy are recommendations on CRT device selection, His bundle pacing and reduction of device-related complications.